Birzeit Pharmaceuticals Company (PEX: BPC)

BPC Revenue

Birzeit Pharmaceuticals Company had revenue of $8.36M USD in the quarter ending June 30, 2024, a decrease of -23.02%. This brings the company's revenue in the last twelve months to $39.51M, down -12.29% year-over-year. In the year 2023, Birzeit Pharmaceuticals Company had annual revenue of $43.13M, down -8.31%.

• Revenue (ttm): $39.51M
• Revenue Growth: -12.29%
• P/S Ratio: 3.63
• Revenue / Employee: $131.71K
• Employees: 300
• Market Cap: 102.99M JOD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	43.13M	-3.91M	-8.31%
Dec 31, 2022	47.03M	1.56M	3.44%
Dec 31, 2021	45.47M	9.62M	26.82%
Dec 31, 2020	35.85M	1.28M	3.70%
Dec 31, 2019	34.58M	-969.76K	-2.73%